I initially thought the phase 2/3b trial was our b
Post# of 144818
![](/assets/46931549/no_avatar_available_thumb.jpg)
Does anyone here have the latest enrollment count for either? With the phase 2, I believe it's just 75 patients, the "treatment window" is 6 weeks but I never heard of any plan for interim results being reviewed. Is there any reason why this is and could this be changed?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)